Pharma & Healthcare Newsletter – March 13 to March 17, 2017

India Infoline News Service | Mumbai | March 18, 2017 12:02 IST

This week, the Parliament has declared on March 14 that National Pharmaceutical Price Authority (NPPA) has received nearly Rs 672.28 cr as fine till date from the pharma companies for overcharging medicines.

Top News
 
Lupin launches Generic Minastrin® 24 Fe chewable tablets in the US
 
Lupin Limited (Lupin) announced today the launch of Mibelas™ 24 Fe (Norethindrone Acetate and Ethinyl Estradiol Chewable Tablets, 1 mg/0.02 mg and Ferrous Fumarate Tablets, 75 mg) having received an approval from the United States Food and Drug Administration (FDA). Read more
 
Govt receives nearly Rs 672 cr as fines from pharma cos
 
The Parliament has declared on March 14 that National Pharmaceutical Price Authority (NPPA) has received nearly Rs 672.28 cr as fine till date from the pharma companies for overcharging medicines. Read more
 

TA Associates plans to invest in pharma firm Ideal Cures
 
The private equity firm headquartered in Boston, TA Associates buys a stake in Mumbai-based Ideal Cures, which supplies coatings for tablets and capsules to the pharmaceutical and allied sectors. Read more

Disclaimer: The contents herein is specifically prepared by ‘Dalal Street Investment Journal’, and is for your information & personal consumption only. India Infoline Limited or Dalal Street Investment Journal do not guarantee the accuracy, correctness, completeness or reliability of information contained herein and shall not be held responsible.

 

Advertisements

  • FREE Demat A/c + Rs.2000 Cashback ...Click here
  • Now get IIFL Personal Loan in just 8* hours...APPLY NOW!
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.
welcome to iifl